Next-Generation Personalized Diabetes Management System

A futuristic, AI-driven diabetes management system that integrates wearable devices, cloud-based analytics, and autonomous insulin delivery to provide real-time, personalized glucose control and insulin dosing recommendations.

Current diabetes management systems rely on manual input and calibration, leading to inaccurate glucose readings and suboptimal insulin dosing. The original patent's personalized parameter modeling methods, while innovative, are limited by their reliance on historical data and lack of real-time adaptability. The new inventive concept addresses these limitations by leveraging machine learning, deep learning, and IoT connectivity to create a proactive, autonomous, and highly personalized diabetes management system.

The next-generation system comprises a wearable device with a non-invasive glucose sensor, a machine learning module, and a communication module. The wearable device transmits real-time glucose data to a cloud-based platform, which analyzes the data using deep learning algorithms to generate personalized glucose prediction models and recommended insulin dosing regimens. The cloud-based platform also integrates data from multiple wearable devices and insulin pumps to provide a comprehensive view of patient glucose trends and insulin delivery patterns. The system's autonomous insulin pump adjusts insulin delivery rates in real-time based on the personalized glucose prediction models and recommended insulin dosing regimens.

The new inventive concept's use of machine learning, deep learning, and IoT connectivity to enable real-time, autonomous, and highly personalized diabetes management represents a significant departure from the original patent's methods. The integration of wearable devices, cloud-based analytics, and autonomous insulin delivery creates a novel and non-obvious system that addresses the limitations of current diabetes management systems.

Alternative embodiments of the inventive concept could include the use of different machine learning algorithms, integration with other health monitoring devices, or the development of specialized algorithms for specific patient populations. Variations of the system could also include different wearable device form factors, cloud-based platform architectures, or autonomous insulin delivery protocols.

The next-generation personalized diabetes management system has significant commercial potential in the diabetes management market, which is projected to reach $12.2 billion by 2025. The system's ability to provide real-time, personalized glucose control and insulin dosing recommendations could improve patient outcomes, reduce healthcare costs, and increase patient adherence to treatment regimens. Target industries include pharmaceutical companies, medical device manufacturers, and healthcare providers.